IM

Ish Mittal

Active Director Managing Director DIN 09640882
DIN 09640882 First appointment Jun 2022 Primary industry Trading
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2022
Shareholding value β€’β€’β€’β€’ Premium profile

About Ish Mittal

Data last updated:

Ish Mittal is a Managing Director at Optimum Pharma Private Limited (since 2022). The company operates in Trading.

DIN 09640882
Primary Designation Managing Director
Industry Trading
First Appointment 16 Jun 2022
Oldest Company Age 4 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Optimum Pharma Private Limited U51909HR2022PTC104427
Managing Director16 Jun 20222022Active

Board colleagues of Ish Mittal

NameDINCompanyDesignation
Amarendra Singh09640993Optimum Pharma Private LimitedManaging Director
Jatinder Rana09640994Optimum Pharma Private LimitedManaging Director

Directorship timeline

Open interactive timeline →
Optimum Pharma Private Limited
Premium access

Shareholding and investment profile for Ish Mittal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ish Mittal

Ish Mittal currently holds 1 directorship: Optimum Pharma Private Limited (Managing Director, since 16 Jun 2022).

Ish Mittal was first appointed on 16 Jun 2022 as Managing Director at Optimum Pharma Private Limited.

The current boards of Ish Mittal's companies include Amarendra Singh (Optimum Pharma Private Limited), Jatinder Rana (Optimum Pharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available